P

Inventor

TUERECI OEZLEM

DE12 patents
⚠️ This page may combine multiple inventors who share the name “TUERECI OEZLEM”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SAHIN UGUR

5 patents
US8637012B2Jan 28, 2014

Genetic products differentially expressed in tumors and the use thereof

SAHIN UGUR18 citations92
US8088588B2Jan 3, 2012

Genetic products differentially expressed in tumors and the use of thereof

SAHIN UGUR17 citations92
US8551490B2Oct 8, 2013

Genetic products differentially expressed in tumors and use thereof

SAHIN UGUR0 citations52
US8088913B2Jan 3, 2012

Compositions and methods for therapy and diagnosis of cancer

SAHIN UGUR0 citations52
US8399210B2Mar 19, 2013

Autoantigenes for improved diagnosis, prognosis and treatment of inflammatory neurological diseases

SAHIN UGUR0 citations45

LUDWIG INST CANCER RES

2 patents
US6140050AOct 31, 2000

Methods for determining breast cancer and melanoma by assaying for a plurality of antigens associated therewith

LUDWIG INST CANCER RES33 citations92
US5888751AMar 30, 1999

Method for diagnosis and treating cancers, and methods for identifying pathogenic markers in a sample of normal cells

LUDWIG INST CANCER RES19 citations92

GANYMED PHARMACEUTICALS AG

2 patents
US7785801B2Aug 31, 2010

Identification of surface-associated antigens for tumor diagnosis and therapy

GANYMED PHARMACEUTICALS AG14 citations91
US7875424B2Jan 25, 2011

Identification of tumour-associated cell surface antigens for diagnosis and therapy

GANYMED PHARMACEUTICALS AG1 citations60

TUERECI OEZLEM

2 patents
US8178653B2May 15, 2012

Recombinant vaccines and use thereof

TUERECI OEZLEM20 citations90
US8637006B2Jan 28, 2014

Recombinant vaccines and use thereof

TUERECI OEZLEM6 citations82

BIONTECH AG

1 patent
US9910043B2Mar 6, 2018

Identification of tumor-associated cell surface antigens for diagnosis and therapy

BIONTECH AG0 citations50